Biliary Tract Cancer Market to Reach $0.95 Billion by 2029, Growing at a CAGR of 7.1%

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Biliary Tract Cancer Industry Expected To Reach By 2029, Starting From 2025 Levels?

The market size for biliary tract cancer has shown robust expansion in recent years. It is projected to increase from $0.67 billion in 2024 to $0.72 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.2%. This historical growth can be attributed to the rising prevalence of biliary tract cancer, the increasing demand for effective treatments, an uptick in risk factors like obesity, an aging populace, and greater investment in research and development.

The biliary tract cancer market is projected to achieve significant expansion in the coming years. Its value is expected to reach $0.95 billion by 2029, progressing at a compound annual growth rate (CAGR) of 7.1%. The increase during the forecast period is driven by factors such as changes in lifestyle, increasing awareness, efforts for early detection, supportive reimbursement policies, and expanding government initiatives. Prominent trends anticipated in this period include technological improvements in diagnosis and treatment, the adoption of immunotherapy, a growing demand for precision medicine, evolving treatment strategies, and advancements in biomarker-based therapies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21114&type=smp

Which Industry Drivers Are Expected To Accelerate The Biliary Tract Cancer Market From 2025 To 2029?

The growing incidence of obesity is anticipated to boost the expansion of the biliary tract cancer market in the future. Obesity, a chronic medical condition, is characterized by an excessive accumulation of body fat that can negatively impact health. The increase in obesity prevalence arises from factors including physical inactivity, psychological influences, age, and genetic and biological predispositions. Obesity initiates chronic inflammation, insulin resistance, and heightened bile acid secretion, potentially leading to DNA damage and tumor growth. It also disrupts hormones and metabolism, fostering a cancer-prone environment within the biliary tract. For instance, in September 2023, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2022, the number of states with an adult obesity rate of 35% or higher has risen to 22, up from 19 in 2021. Consequently, the expanding prevalence of obesity is a key driver for the growth of the biliary tract cancer market.

What Are The Major Segment Categories Driving The Biliary Tract Cancer Market Growth?

The biliary tract cancermarket covered in this report is segmented –

1) By Cancer Type: Intrahepatic Bile Duct Cancer; Extrahepatic Bile Duct Cancer; Gallbladder Cancer

2) By Treatment: Chemotherapy; Targeted Therapy; Immunotherapy

3) By End-User: Hospitals; Specialty Cancer Centres; Ambulatory Surgical Centres; Other End-Users

Subsegments:

1) By Intrahepatic Bile Duct Cancer: Peripheral Intrahepatic Bile Duct Cancer; Hilar Intrahepatic Bile Duct Cancer

2) By Extrahepatic Bile Duct Cancer: Perihilar Bile Duct Cancer; Distal Bile Duct Cancer

3) By Gallbladder Cancer: Localized Gallbladder Cancer; Advanced Gallbladder Cancer

Which Ongoing Trends Are Expected To Shape The Biliary Tract Cancer Market Outlook?

Leading companies in the biliary tract cancer market are increasingly focused on developing advanced combination treatments to boost efficacy and improve patient outcomes. This therapeutic approach involves using two or more medications or treatment modalities concurrently to address a single disease. For example, in November 2023, Merck & Co. Inc., a US-based pharmaceutical company, secured U.S. Food and Drug Administration (FDA) approval for KEYTRUDA (pembrolizumab) used in combination with gemcitabine and cisplatin for treating patients with locally advanced unresectable or metastatic biliary tract cancer (BTC). This authorization was granted based on findings from the Phase 3 KEYNOTE-966 trial, which revealed a statistically significant improvement in overall survival, decreasing the risk of death by 17% when compared to chemotherapy alone. Patients receiving the combination therapy had a median overall survival of 12.7 months, as opposed to 10.9 months for those on chemotherapy only, signifying a notable progression in available treatments for this challenging type of cancer.

Who Are The Major Companies Operating In The Biliary Tract Cancer Market?

Major companies operating in the biliary tract cancer market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca Plc, Eli Lily and Company, Boehringer Ingelheim International GmbH, Eisai Co. Ltd., Servier Pharmaceuticals, Jazz Pharmaceuticals plc, Incyte Corporation, BeiGene LTD., Zymeworks, Basilea Pharmaceutica Ltd., Taiho Oncology Inc., RenovoRx Inc., TransThera Sciences Inc., QED Therapeutics Inc., Helsinn Group

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/biliary-tract-cancer-global-market-report

What Are The Key Regional Factors Influencing The Biliary Tract Cancer Market Growth?

North America was the largest region in the biliary tract cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biliary tract cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Biliary Tract Cancer Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21114&type=smp

Browse Through More Reports Similar to the Global Biliary Tract Cancer Market 2025, By The Business Research Company

Cervical Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cervical-cancer-drugs-global-market-report

Colorectal Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/colorectal-cancer-drugs-global-market-report

Kidney Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/kidney-cancer-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795